Furthermore, SGLT2 inhibitors positively influence metabolic pathways related to insulin sensitivity and lipid metabolism, offering a multifaceted approach to diabetes management by controlling blood glucose levels and providing ancillary benefits such as weight reduction and cardiovascular protection [242]. The gene discussed is SLC5A2; the disease is diabetes mellitus.